Partner at Carpmaels & Ransford LLP
Daniel Wise specialises in biologics and pharmaceuticals, with particular expertise in protein therapeutics, vaccine technology and medicinal chemistry. Much of his time is spent handling European Patent Office (EPO) opposition proceedings, in which he has extensive experience in attack and defence, both at first instance and appeal. Mr Wise particularly enjoys representing clients at EPO hearings and has been involved in many multi-party disputes. He supports European national patent litigations and has coordinated EPO strategy with several pan-European litigations in the antibody and blood protein fields. This experience has included the successful revocation of several platform patents during innovator-on-innovator disputes in the biologics field.
Aside from his opposition practice, Mr Wise carries out a range of patent work, including original drafting, prosecution at the EPO and overseas, opinions and freedom-to-operate analyses. He is passionate about helping clients to bring their innovative medicines to market, with robust protection and freedom from competitor patents. He has an in-depth knowledge of the complex world of supplementary protection certificates (SPCs) for authorised medicines, having coordinated several business-critical SPC portfolios across the European Union and advised on the infringement and validity of various third-party SPCs. As head of Carpmaels & Ransford’s SPC group, Mr Wise has worked on leading SPC cases at the European Court of Justice, including the widely cited Queensland (C-630/10) and Neurim (C-130/11) referrals. He also sits on the Chartered Institute of Patent Attorneys SPC subcommittee, which advises the UK government on SPC matters.
Before entering the legal profession, Mr Wise studied natural sciences at Cambridge University. He specialised in biochemistry, organic chemistry and molecular biology and carried out research into the mechanisms of platelet activation in human blood. He also spent a summer at Yale University investigating the genetics of protein trafficking in yeast.